Compare · ASML vs MLAB
ASML vs MLAB
Side-by-side comparison of ASML Holding N.V. New York Registry Shares (ASML) and Mesa Laboratories Inc. (MLAB): market cap, price performance, sector, and recent activity on the wire.
Summary
- ASML operates in Technology, while MLAB operates in Industrials - the two are in different parts of the market.
- ASML is the larger of the two at $672.23B, about 943.3x MLAB ($712.6M).
- Over the past year, ASML is up 128.5% and MLAB is up 84.6% - ASML leads by 43.9 points.
- MLAB has been more active in the news (13 items in the past 4 weeks vs 1 for ASML).
- ASML has more recent analyst coverage (25 ratings vs 3 for MLAB).
- Company
- ASML Holding N.V. New York Registry Shares
- Mesa Laboratories Inc.
- Price
- $1743.61+0.18%
- $128.13+3.12%
- Market cap
- $672.23B
- $712.6M
- 1M return
- +5.33%
- +32.24%
- 1Y return
- +128.48%
- +84.59%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1995
- News (4w)
- 1
- 13
- Recent ratings
- 25
- 3
ASML Holding N.V. New York Registry Shares
ASML Holding N.V. develops, produces, markets, sells, and services advanced semiconductor equipment systems consisting of lithography, metrology, and inspection related systems for memory and logic chipmakers. The company provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography solutions to manufacture various range of semiconductor nodes and technologies. It also offers metrology and inspection systems, including YieldStar optical metrology solutions to measure the quality of patterns on the wafers; and HMI e-beam solutions to locate and analyze individual chip defects. In addition, the company provides computational lithography and software solutions to create applications that enhance the setup of the lithography system; and mature products and services that refurbish used lithography equipment and offers associated services. It operates in Japan, South Korea, Singapore, Taiwan, China, the Netherlands, Europe, the Middle East, Africa, the United States, and rest of Asia. The company was formerly known as ASM Lithography Holding N.V. and changed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.
Mesa Laboratories Inc.
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The company's Instruments segment designs, manufactures, and markets quality control hardware and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. This segment's products include dialysate meters and calibration solutions, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company's Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Continuous Monitoring segment designs, develops, and markets systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Latest ASML
- ASML reports transactions under its current share buyback program
- ASML reports transactions under its current share buyback program
- SEC Form 6-K filed by ASML Holding N.V. New York Registry Shares
- High NA EUV reaches new readiness milestone with first high-volume Logic product
- ASML reports €9.3 billion total net sales and €2.9 billion net income in Q2 2026
- RBC Capital Mkts reiterated coverage on ASML with a new price target
- ASML reports transactions under its current share buyback program
- SEC Form SD filed by ASML Holding N.V. New York Registry Shares
- ASML reports transactions under its current share buyback program
- ASML reports transactions under its current share buyback program
Latest MLAB
- Director Capone Mark Christopher converted options into 2,784 shares, increasing direct ownership by 81% to 6,213 units (SEC Form 4)
- Director Alltoft Jennifer Sadie converted options into 2,784 shares, increasing direct ownership by 57% to 7,662 units (SEC Form 4)
- Director Ladiwala Shiraz Shabanali converted options into 3,810 shares, increasing direct ownership by 45% to 12,333 units (SEC Form 4)
- Director Hall Shannon converted options into 2,784 shares, increasing direct ownership by 66% to 6,973 units (SEC Form 4)
- Director Tripeny R Tony converted options into 2,784 shares, increasing direct ownership by 44% to 9,082 units (SEC Form 4)
- Director Sullivan John James converted options into 2,784 shares, increasing direct ownership by 16% to 20,618 units (SEC Form 4)
- Director Sullivan John James sold $800,090 worth of shares (7,093 units at $112.80), decreasing direct ownership by 28% to 17,834 units (SEC Form 4)
- President and CEO Kadia Siddhartha bought $800,090 worth of shares (7,093 units at $112.80) (SEC Form 4)
- Director Tripeny R Tony bought $102,321 worth of shares (900 units at $113.69), increasing direct ownership by 17% to 6,298 units (SEC Form 4)
- SEC Form 10-Q filed by Mesa Laboratories Inc.